ESR1 and breast cancer: Our observed association of increased risk with respect to rs2046210 (ESR1) was consistent with previous studies suggesting that rs2046210 tended to increase BC risk in ER− tumour by a greater magnitude as compared to ER+ tumour32, 33, 34.